Vaccine against Ebola: Commission grants first-ever market authorisation

European Commission – Press release Brussels, 11 November 2019 Today, the European Commission adopted the decision granting marketing authorisation to the company Merck Sharp & Dohme B.V. for a vaccine against Ebola. This vaccine, called Ervebo, had been in development since the Ebola outbreak in West Africa in 2014.
Source: Comunicati Stampa EU

Questa voce è stata pubblicata in EU News. Contrassegna il permalink.